withdrawal from tirzepatide Study shows that 82% saw weight rebound and cardiovascular health reverse after taking GLP-1 drugs Tirzepatide vs Semaglutide | Best

Hydration matters too: many patients on GLP-1 therapy undereat because they confuse thirst with hunger, so drinking 8-10 glasses of water daily helps distinguish genuine appetite from dehydration signals

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

It provides early evidence that future studies are worth pursuing. Three other types of cancer prostate, pancreatic and kidney also had lower rates of spread among those taking GLP-1s, but those differences were not statistically significant, the researchers noted

Abboud M, Alexander D., Najjar S